APO Research
Talk to an analyst

APO RESEARCH · REPORT

Maternal Mental Health

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Maternal Mental Health Market Outlook and Growth Opportunities 2026

4 March 2026197 pages

Choose your research edition.

Industry ResearchMaternal Mental Health Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Maternal Mental Health Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Maternal Mental Health Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Maternal Mental Health Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Maternal Mental Health Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Maternal Mental Health market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Maternal Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Maternal Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Maternal Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Maternal Mental Health market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Maternal Mental Health market include Lipocine, Pfizer, Viatris, Bold Health, Glaxo Smith Kline Inc., Alembic Pharmaceuticals Limited, Mallinckrodt, Sage Therapeutics, Inc. and Bausch Health Companies Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Maternal Mental Health market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Maternal Mental Health and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Maternal Mental Health revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Maternal Mental Health market.

Maternal Mental Health Segment by Company

Lipocine

Pfizer

Viatris

Bold Health

Glaxo Smith Kline Inc.

Alembic Pharmaceuticals Limited

Mallinckrodt

Sage Therapeutics, Inc.

Bausch Health Companies Inc.

Magellan Health

Maternal Mental Health Segment by Type

Antidepressants

Interpersonal Psychotherapy

Cognitive Behavioural Therapy

Others

Maternal Mental Health Segment by Application

Clinics

Hospitals

Others

Maternal Mental Health Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Maternal Mental Health status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Maternal Mental Health key companies, revenue, market share, and recent developments.

3. To split the Maternal Mental Health breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Maternal Mental Health market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Maternal Mental Health significant trends, drivers, influence factors in global and regions.

6. To analyze Maternal Mental Health competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Maternal Mental Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Maternal Mental Health and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Maternal Mental Health.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Maternal Mental Health industry.

Chapter 3: Detailed analysis of Maternal Mental Health company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Maternal Mental Health in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Maternal Mental Health in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Maternal Mental Health Industry Trends Table 2. Maternal Mental Health Industry Drivers Table 3. Maternal Mental Health Industry Opportunities and Challenges Table 4. Maternal Mental Health Industry Restraints Table 5. Global Maternal Mental Health Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Maternal Mental Health Revenue Share by Company (2021-2026) Table 7. Global Maternal Mental Health Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Maternal Mental Health Key Company Manufacturing Base & Headquarters Table 9. Global Maternal Mental Health Company, Product Type & Application Table 10. Global Maternal Mental Health Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Maternal Mental Health by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Antidepressants Table 15. Significant Companies of Interpersonal Psychotherapy Table 16. Significant Companies of Cognitive Behavioural Therapy Table 17. Significant Companies of Others Table 18. Global Maternal Mental Health Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Maternal Mental Health Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Maternal Mental Health Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Maternal Mental Health Sales Value Share by Type (2021-2026) Table 22. Global Maternal Mental Health Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Clinics Table 24. Significant Companies of Hospitals Table 25. Significant Companies of Others Table 26. Global Maternal Mental Health Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Maternal Mental Health Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Maternal Mental Health Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Maternal Mental Health Sales Value Share by Application (2021-2026) Table 30. Global Maternal Mental Health Sales Value Share by Application (2027-2032) Table 31. Global Maternal Mental Health Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Maternal Mental Health Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Maternal Mental Health Sales Value Share by Region (2021-2026) Table 34. Global Maternal Mental Health Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Maternal Mental Health Sales Value Share by Region (2027-2032) Table 36. Global Maternal Mental Health Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Maternal Mental Health Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Maternal Mental Health Sales Value Market Share by Country (2021-2026) Table 39. Global Maternal Mental Health Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Maternal Mental Health Sales Value Market Share by Country (2027-2032) Table 41. Lipocine Company Information Table 42. Lipocine Business Overview Table 43. Lipocine Maternal Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Lipocine Maternal Mental Health Product Portfolio Table 45. Lipocine Recent Development Table 46. Pfizer Company Information Table 47. Pfizer Business Overview Table 48. Pfizer Maternal Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Pfizer Maternal Mental Health Product Portfolio Table 50. Pfizer Recent Development Table 51. Viatris Company Information Table 52. Viatris Business Overview Table 53. Viatris Maternal Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Viatris Maternal Mental Health Product Portfolio Table 55. Viatris Recent Development Table 56. Bold Health Company Information Table 57. Bold Health Business Overview Table 58. Bold Health Maternal Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Bold Health Maternal Mental Health Product Portfolio Table 60. Bold Health Recent Development Table 61. Glaxo Smith Kline Inc. Company Information Table 62. Glaxo Smith Kline Inc. Business Overview Table 63. Glaxo Smith Kline Inc. Maternal Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Glaxo Smith Kline Inc. Maternal Mental Health Product Portfolio Table 65. Glaxo Smith Kline Inc. Recent Development Table 66. Alembic Pharmaceuticals Limited Company Information Table 67. Alembic Pharmaceuticals Limited Business Overview Table 68. Alembic Pharmaceuticals Limited Maternal Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Alembic Pharmaceuticals Limited Maternal Mental Health Product Portfolio Table 70. Alembic Pharmaceuticals Limited Recent Development Table 71. Mallinckrodt Company Information Table 72. Mallinckrodt Business Overview Table 73. Mallinckrodt Maternal Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Mallinckrodt Maternal Mental Health Product Portfolio Table 75. Mallinckrodt Recent Development Table 76. Sage Therapeutics, Inc. Company Information Table 77. Sage Therapeutics, Inc. Business Overview Table 78. Sage Therapeutics, Inc. Maternal Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Sage Therapeutics, Inc. Maternal Mental Health Product Portfolio Table 80. Sage Therapeutics, Inc. Recent Development Table 81. Bausch Health Companies Inc. Company Information Table 82. Bausch Health Companies Inc. Business Overview Table 83. Bausch Health Companies Inc. Maternal Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Bausch Health Companies Inc. Maternal Mental Health Product Portfolio Table 85. Bausch Health Companies Inc. Recent Development Table 86. Magellan Health Company Information Table 87. Magellan Health Business Overview Table 88. Magellan Health Maternal Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Magellan Health Maternal Mental Health Product Portfolio Table 90. Magellan Health Recent Development Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Maternal Mental Health Product Image Figure 2. Global Maternal Mental Health Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Maternal Mental Health Market Size (2021-2032) & (US$ Million) Figure 4. Global Maternal Mental Health Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Antidepressants Image Figure 8. Interpersonal Psychotherapy Image Figure 9. Cognitive Behavioural Therapy Image Figure 10. Others Image Figure 11. Global Maternal Mental Health Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Maternal Mental Health Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Maternal Mental Health Sales Value Share by Type (2021-2032) Figure 14. Clinics Image Figure 15. Hospitals Image Figure 16. Others Image Figure 17. Global Maternal Mental Health Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Maternal Mental Health Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Maternal Mental Health Sales Value Share by Application (2021-2032) Figure 20. Global Maternal Mental Health Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Maternal Mental Health Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Maternal Mental Health Sales Value (2021-2032) & (US$ Million) Figure 23. North America Maternal Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Maternal Mental Health Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Maternal Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Maternal Mental Health Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Maternal Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Maternal Mental Health Sales Value (2021-2032) & (US$ Million) Figure 29. South America Maternal Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Maternal Mental Health Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Maternal Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Maternal Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Maternal Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Maternal Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Antidepressants
  • Interpersonal Psychotherapy
  • Cognitive Behavioural Therapy
  • Others
Applications
  • Clinics
  • Hospitals
  • Others
Companies covered
  • Lipocine
  • Pfizer
  • Viatris
  • Bold Health
  • Glaxo Smith Kline Inc.
  • Alembic Pharmaceuticals Limited
  • Mallinckrodt
  • Sage Therapeutics, Inc.
  • Bausch Health Companies Inc.
  • Magellan Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Maternal Mental Health Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Maternal Mental Health Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Maternal Mental Health Market Dynamics
  1. 2.1 Maternal Mental Health Industry Trends
  2. 2.2 Maternal Mental Health Industry Drivers
  3. 2.3 Maternal Mental Health Industry Opportunities and Challenges
  4. 2.4 Maternal Mental Health Industry Restraints
3 Maternal Mental Health Market by Company
  1. 3.1 Global Maternal Mental Health Company Revenue Ranking in 2025
  2. 3.2 Global Maternal Mental Health Revenue by Company (2021-2026)
  3. 3.3 Global Maternal Mental Health Company Ranking (2024-2026)
  4. 3.4 Global Maternal Mental Health Company Manufacturing Base and Headquarters
  5. 3.5 Global Maternal Mental Health Company Product Type and Application
  6. 3.6 Global Maternal Mental Health Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Maternal Mental Health Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Maternal Mental Health Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Maternal Mental Health Market by Type
  1. 4.1 Maternal Mental Health Type Introduction
  2. 4.1.1 Antidepressants
  3. 4.1.2 Interpersonal Psychotherapy
  4. 4.1.3 Cognitive Behavioural Therapy
  5. 4.1.4 Others
  6. 4.2 Global Maternal Mental Health Sales Value by Type
  7. 4.2.1 Global Maternal Mental Health Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Maternal Mental Health Sales Value by Type (2021-2032)
  9. 4.2.3 Global Maternal Mental Health Sales Value Share by Type (2021-2032)
5 Maternal Mental Health Market by Application
  1. 5.1 Maternal Mental Health Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Others
  5. 5.2 Global Maternal Mental Health Sales Value by Application
  6. 5.2.1 Global Maternal Mental Health Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Maternal Mental Health Sales Value by Application (2021-2032)
  8. 5.2.3 Global Maternal Mental Health Sales Value Share by Application (2021-2032)
6 Maternal Mental Health Regional Value Analysis
  1. 6.1 Global Maternal Mental Health Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Maternal Mental Health Sales Value by Region (2021-2032)
  3. 6.2.1 Global Maternal Mental Health Sales Value by Region: 2021-2026
  4. 6.2.2 Global Maternal Mental Health Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Maternal Mental Health Sales Value (2021-2032)
  7. 6.3.2 North America Maternal Mental Health Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Maternal Mental Health Sales Value (2021-2032)
  10. 6.4.2 Europe Maternal Mental Health Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Maternal Mental Health Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Maternal Mental Health Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Maternal Mental Health Sales Value (2021-2032)
  16. 6.6.2 South America Maternal Mental Health Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Maternal Mental Health Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Maternal Mental Health Sales Value Share by Country, 2025 VS 2032
7 Maternal Mental Health Country-level Value Analysis
  1. 7.1 Global Maternal Mental Health Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Maternal Mental Health Sales Value by Country (2021-2032)
  3. 7.2.1 Global Maternal Mental Health Sales Value by Country (2021-2026)
  4. 7.2.2 Global Maternal Mental Health Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Maternal Mental Health Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Maternal Mental Health Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Maternal Mental Health Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Maternal Mental Health Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Maternal Mental Health Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Maternal Mental Health Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Maternal Mental Health Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Maternal Mental Health Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Maternal Mental Health Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Maternal Mental Health Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Maternal Mental Health Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Maternal Mental Health Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Maternal Mental Health Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Maternal Mental Health Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Maternal Mental Health Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Maternal Mental Health Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Maternal Mental Health Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Maternal Mental Health Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Maternal Mental Health Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Maternal Mental Health Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Maternal Mental Health Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Maternal Mental Health Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Maternal Mental Health Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Maternal Mental Health Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Maternal Mental Health Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Maternal Mental Health Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Maternal Mental Health Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Maternal Mental Health Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Maternal Mental Health Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Maternal Mental Health Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lipocine
  2. 8.1.1 Lipocine Company Information
  3. 8.1.2 Lipocine Business Overview
  4. 8.1.3 Lipocine Maternal Mental Health Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lipocine Maternal Mental Health Product Portfolio
  6. 8.1.5 Lipocine Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Maternal Mental Health Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Maternal Mental Health Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Viatris
  14. 8.3.1 Viatris Company Information
  15. 8.3.2 Viatris Business Overview
  16. 8.3.3 Viatris Maternal Mental Health Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Viatris Maternal Mental Health Product Portfolio
  18. 8.3.5 Viatris Recent Developments
  19. 8.4 Bold Health
  20. 8.4.1 Bold Health Company Information
  21. 8.4.2 Bold Health Business Overview
  22. 8.4.3 Bold Health Maternal Mental Health Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bold Health Maternal Mental Health Product Portfolio
  24. 8.4.5 Bold Health Recent Developments
  25. 8.5 Glaxo Smith Kline Inc.
  26. 8.5.1 Glaxo Smith Kline Inc. Company Information
  27. 8.5.2 Glaxo Smith Kline Inc. Business Overview
  28. 8.5.3 Glaxo Smith Kline Inc. Maternal Mental Health Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Glaxo Smith Kline Inc. Maternal Mental Health Product Portfolio
  30. 8.5.5 Glaxo Smith Kline Inc. Recent Developments
  31. 8.6 Alembic Pharmaceuticals Limited
  32. 8.6.1 Alembic Pharmaceuticals Limited Company Information
  33. 8.6.2 Alembic Pharmaceuticals Limited Business Overview
  34. 8.6.3 Alembic Pharmaceuticals Limited Maternal Mental Health Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Alembic Pharmaceuticals Limited Maternal Mental Health Product Portfolio
  36. 8.6.5 Alembic Pharmaceuticals Limited Recent Developments
  37. 8.7 Mallinckrodt
  38. 8.7.1 Mallinckrodt Company Information
  39. 8.7.2 Mallinckrodt Business Overview
  40. 8.7.3 Mallinckrodt Maternal Mental Health Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mallinckrodt Maternal Mental Health Product Portfolio
  42. 8.7.5 Mallinckrodt Recent Developments
  43. 8.8 Sage Therapeutics, Inc.
  44. 8.8.1 Sage Therapeutics, Inc. Company Information
  45. 8.8.2 Sage Therapeutics, Inc. Business Overview
  46. 8.8.3 Sage Therapeutics, Inc. Maternal Mental Health Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sage Therapeutics, Inc. Maternal Mental Health Product Portfolio
  48. 8.8.5 Sage Therapeutics, Inc. Recent Developments
  49. 8.9 Bausch Health Companies Inc.
  50. 8.9.1 Bausch Health Companies Inc. Company Information
  51. 8.9.2 Bausch Health Companies Inc. Business Overview
  52. 8.9.3 Bausch Health Companies Inc. Maternal Mental Health Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bausch Health Companies Inc. Maternal Mental Health Product Portfolio
  54. 8.9.5 Bausch Health Companies Inc. Recent Developments
  55. 8.10 Magellan Health
  56. 8.10.1 Magellan Health Company Information
  57. 8.10.2 Magellan Health Business Overview
  58. 8.10.3 Magellan Health Maternal Mental Health Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Magellan Health Maternal Mental Health Product Portfolio
  60. 8.10.5 Magellan Health Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst